DWA
SLXP

Dorsey Wright & Associates’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Dorsey Wright & Associates’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14,441
Closed -$2.26M – 151
2014
Q3 		$2.26M Sell
14,441
-134
-0.9% -$19.4K 0.32% 38
2014
Q2 		$1.93M Sell
14,575
-321
-2% -$35.5K 0.23% 47
2014
Q1 		$1.64M Sell
14,896
-883
-6% -$90.4K 0.23% 44
2013
Q4 		$1.5M Buy
+15,779
New +$1.26M 0.22% 49

Other funds holding SLXP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dorsey Wright & Associates's SLXP Position: Q4 2014 in Review

Dorsey Wright & Associates sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q4 2014, closing a stake of 14,441 shares — an estimated $2.26M sold.

Dorsey Wright & Associates first reported a position in SLXP in Q4 2013 and held it in 4 quarters. The position peaked at $2.26M in Q3 2014. 346 funds tracked by Wall St. Rank hold SLXP as of Q4 2014.

  • Dorsey Wright & Associates reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q4 2014 after selling out during the quarter.
  • Dorsey Wright & Associates sold 14,441 SALIX PHARMACEUTICALS LTD DEL shares in Q4 2014, an estimated $2.26M.
  • Dorsey Wright & Associates first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q4 2013 and held it in 4 quarters.
  • Dorsey Wright & Associates's SALIX PHARMACEUTICALS LTD DEL position peaked at $2.26M in Q3 2014.
  • 346 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q4 2014.

Based on Dorsey Wright & Associates's 13F filing for Q4 2014, filed 9 Jan 2015.